We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£82.62
It has never been this cheap. We have no record of a lower price.
£83 today · cheaper than every other day in the last 3 months
Elsevier Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 64 days · 64 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 64 days • 4 price levels
Current Price
Price Analysis
Most common price: £84 (37 days, 57.8%)
Price range: £83 - £88
Price levels: 4 different prices over 64 days
Description
Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors explores trace amines which, under normal conditions, are present in the mammalian brain and peripheral nervous tissues at very low (nanomolar) concentrations. However, in a diverse array of human pathologies ranging from substance abuse, depression, attention deficit hyperactivity disorder, eating disorders, schizophrenia, and other neurological and neuropsychiatric diseases, the levels of trace amines are unusually high with an imbalance in their functions. Furthermore, the rapid turnover of trace amines is evidenced by their dramatic increases following treatment with monoamine oxidase inhibitors (MAOI) or deletion of the MAO genes. This suggests that the concentration of trace amines may be considerably higher at neuronal synapses than predicted by steady-state measures, implicating some pathophysiological role. Therefore, understanding molecular mechanisms and developing selective agonists and antagonists for trace amine-associated receptors (TAARs) has become a good approach for treating these diseases. Although the effects of trace amines at low physiological concentrations in mammalian species have been difficult to demonstrate, they may serve to maintain the neuronal activity of other monoamine neurotransmitters by possessing postsynaptic modulatory effects, particularly dopamine and serotonin, within defined physiological limits. Such an effect of trace amines makes them ideal candidates for the development of novel therapeutics for a wide range of human disorders. This book presents up-to-date, cutting-edge, and comprehensive information on the link between trace amines and neurological disorders. * Focuses on recent findings on trace amines, providing insights into the functional significance, molecular mechanisms, and biological relevance of TAARS in neurological disorders* Edited work with chapters authored by leaders in the field from around the globe, the broadest, most expert coverage available* Provides cutting-edge research on trace amines-mediated signaling in vertebrate model systems
Product Specifications
- Brand
- Elsevier
- Format
- hardcover
- ASIN
- 0128036036
- Domain
- Amazon UK
- Release Date
- 01 August 2016
- Listed Since
- 02 May 2016
Barcode
No barcode data available
Similar Products You Might Like
96% match
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
Humana
£165.06
03 Sep 2026
96% match
Neuropsychopharmacology of the Trace Amines: Experimental and Clinical Aspects (Experimental and Clinical Neuroscience)
Humana
£141.86
02 Oct 2026
96% match
Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)
Humana
£136.54
24 Sep 2026
96% match
Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward
£85.65
17 Sep 2026
96% match
Behavioral Neurogenomics: 42 (Current Topics in Behavioral Neurosciences, 42)
Springer
£100.11
02 Oct 2026
96% match
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
Humana
£141.67
24 Sep 2026
96% match
Chemical Biology of Neurodegeneration: Molecular Approach
Wiley
£104.00
16 Sep 2026
95% match
Neurotoxin Modeling of Brain Disorders ― Life-long Outcomes in Behavioral Teratology: 29 (Current Topics in Behavioral Neurosciences, 29)
Springer
£109.08
28 Aug 2026
95% match
Ketamine for Treatment-Resistant Depression: The First Decade of Progress
Adis
£65.61
23 Sep 2026
95% match
Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)
Elsevier
£129.00
01 Oct 2026
95% match
Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment
Springer
£114.88
02 Oct 2026
95% match
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
Humana
£81.06
26 Sep 2026
95% match
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
Humana
£104.34
17 Sep 2026
95% match
Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks
£186.89
04 Sep 2026
95% match
Academic Press Handbook of Behavioral Neurobiology of Serotonin
Elsevier
£135.00
01 Oct 2026
95% match
Neurophenotypes: Advancing Psychiatry and Neuropsychology in the "OMICS" Era (Innovations in Cognitive Neuroscience)
Springer
£92.06
01 Oct 2026
95% match
Neuropsychopharmacology: 64 (Journal of Neural Transmission. Supplementa, 64)
Springer
£82.00
18 Sep 2026
95% match
Dopamine (Volume 211) (Progress in Brain Research, Volume 211)
Elsevier
£172.19
25 Aug 2026
95% match
Drug Discovery for Psychiatric Disorders: Volume 28 (Drug Discovery Series)
Royal Society of Chemistry
£72.56
24 Sep 2026
95% match
Dopamine Receptor Technologies: 96 (Neuromethods, 96)
Humana
£79.93
01 Oct 2026
95% match
Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172
Elsevier
£182.59
25 Sep 2026
95% match
Serotonin: The Mediator that Spans Evolution - Academic Press
Elsevier
£136.99
02 Oct 2026
95% match
Massachusetts General Hospital Psychopharmacology and Neurotherapeutics
Elsevier
£55.53
21 Aug 2026
95% match
Translational Neuropsychopharmacology: 28 (Current Topics in Behavioral Neurosciences, 28)
Springer
£109.64
01 Oct 2026